Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Amgen v. Transkaryotic Therapies: Case Study of the Interrelatedness Between Patent and FDA Laws

Biotechnology Law Report

Impact Factor: 0.3 / 5-Year Impact Factor: 0.3

Journal Homepage Submission guidelines

Restricted access

Research article

First published online August, 2001

Amgen v. Transkaryotic Therapies: Case Study of the Interrelatedness Between Patent and FDA Laws

Volume 20, Issue 4

https://doi.org/10.1089/07300310152543952

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

House Committee On Science And Technology Issues Report On Recent Advances In Plant Sciences

Restricted access

{BLR 1754}Bio - Carl Feldbaum - Sen. Nancy Kassebaum - Sen. Edward M. Kennedy - Sen. Howard M. Metzenbaum - Abbey Meyers - Orphan Drugs - Nord - Rep. Gerry E. Studds - Rep. Henry A. Waxman

Restricted access

{BLR 1692}Dr. W. French Anderson - Familial Hypercholesterolemia - Gene Therapy

Restricted access

Top Patent Cases Related to Biotechnology